Tim Xu discusses new data from Amplyx
21st July 2020
Tim Xu, MD, discusses recent Phase 2 data from Arix portfolio company Amplyx and why anti-infectives are especially important now during the pandemic
Stay Updated
Add your email below to stay updated with useful and informative content from Arix and our portfolio companies